Journal of Southern Medical University ›› 2006, Vol. 26 ›› Issue (02): 169-173.

Previous Articles     Next Articles

siRNA targeted against survivin induces apoptosis of pancreatic cancer cells

GUAN Hai-tao, XUE Xing-huan, WANG Xi-jing, LI Ang, QIN Zhao-yin Department of Oncologic Surgery, Department of General Surgery, Second Hospital of Xi’an Jiaotong University;MedicaI Research Center, Stomatological Hospital of Xi’an Jiaotong University, Xi’an 710004, China   

  1. 西安交通大学第二医院肿瘤外科; 西安交通大学口腔医院医学研究中心; 西安交通大学第二医院普通外科 710004; 710004; 陕西西安710004;
  • Online:2006-02-20 Published:2006-02-20

Abstract: Objective To investigate the effect of a sequence-specific small interfering RNA (siRNA) in suppressing survivin expression and cell proliferation and inducing apoptosis of PC-2 cells. Methods The plasmid expression vector of siRNA targeted against survivin was constructed and transfected into PC-2 cells with Lipofectamine?000. The changes of survivin expression were detected by semi-quantitative RT-PCR and immunohistochemical SP methods. The effect of siRNA in suppressing the proliferation of PC-2 cells was detected by MTT assay, and its role in inducing PC-2 cell apoptosis evaluated by flow cytometry. Results The sequence-specific siRNA effectively suppressed survivin expression at both mRNA and protein levels with inhibition rate of 81.25% at mRNA level and 74.24% at protein level. Survivin expression suppression significantly inhibited the proliferation of PC-2 cells, and at 24 and 48 h after cell seeding, the proliferation inhibition rate was 28.00% and 33.38% respectively; 24, 48 h after the transfection, apoptosis occurred in 8.46% and 7.53% of the cells, respectively. Conclusions The plasmid expression vector for the siRNA against survivin constructed in the study can effectively and specifically suppress survivin expression in PC-2 cells, and blocking survivin expression suppresses PC-2 cell proliferation and induces cell apoptosis. siRNA targeted against survivin has a potential value in gene therapy for pancreatic cancer. 

CLC Number: